Videos, articles & case studies.

Sushma Rajagopalan and Steven Schaefer join the Board as the company secures new financing to accelerate growth of its AI commercial intelligence platform  BOSTON, Mass. — July 8, 2026 — S2N Health, Inc., a leading provider of commercial intelligence solutions for medtech and life […] Read More

How S2N built Tactile Medical a custom predictive algorithm to score and prioritize physician opportunities, surfacing 8,200+ net-new targets directly in Salesforce and saving the sales team 4 hours of planning time every week. Company Background Tactile Medical is a […] Read More

National and strategic accounts teams have become more important than ever in the MedTech space, largely due to the rise and consolidation of integrated delivery networks (IDNs).  In this conversation, Murray Sales, Former Sr. Managing Director of Strategic Accounts at […] Read More

Entering a new market is one of the highest-stakes moves in any MedTech go-to-market strategy. The product may be innovative, the clinical data compelling, and the commercial team ready to execute. But without the right market intelligence, even the best medical device launch […] Read More

How embedding deep customer & market intelligence inside Salesforce transformed the CRM from an administrative tool into a daily decision-making platform for the field. At a Glance: How Cagent Vascular Transformed CRM Adoption Cagent Vascular, an innovator in endovascular therapy […] Read More

In 2025, Becker’s Hospital Review surveyed 61 senior strategy executives leading health systems with $1 billion+ in annual revenue. 97% of respondents cited investing in new tech-related capabilities as their top priority.  This survey indicates that top-level decision makers at […] Read More

MedTech commercialization is changing. As care delivery becomes more complex and buyers more sophisticated, traditional product-led selling is no longer enough. Today’s customers expect insight into patients, pathways, economics, and real-world adoption dynamics, not just product differentiation.  This has made […] Read More

National and strategic accounts teams are navigating a far more complex MedTech environment than they were a decade ago. Health systems are larger and more consolidated, portfolios span multiple business units and sites of care, and leaders are increasingly accountable for ensuring contracts deliver real, […] Read More

Today’s MedTech sales reps exist in a pressure-packed commercial environment, facing an impossible equation: territories keep expanding, quotas keep rising, but the hours in a day stay exactly the same. The difference between hitting and missing quota often comes down […] Read More

In today’s tightened commercial environment, MedTech sales teams can’t afford to waste cycles on accounts where reimbursement friction slows adoption. Coverage varies widely across hospitals, health systems, and ASCs—and even high-volume procedural sites can be financially unfavorable for your product […] Read More

There is major market movement underway in the cardiac ablation space, with huge implications for MedTech. In late November, CMS released their CY 2026 OPPS/ASC Final Rule, which adds cardiac catheter ablation to the ASC Covered Procedures List, allowing Medicare […] Read More

Bringing innovative medical technologies to market is more complex than ever. Today’s commercial leaders face shifting care settings, mounting cost pressures, enterprise-level risk considerations, and intensifying market competition. So what separates the companies that quickly gain market traction from those […] Read More

Why Leading MedTech Companies Trust S2N Health’s Custom Market Modeling and Forecasting Tools Market sizing isn’t one-size-fits-all. Every medical device market behaves differently — by procedure type, care setting, adoption rate, and referral pattern — yet many commercial intelligence and […] Read More

(With insights from Raj Khalsa, MD, Chief of Vascular & Interventional Radiology at Harbor-UCLA) In medical device sales, few things are more valuable than a rep who truly understands the physician’s world. To explore what makes these relationships effective—and how data and […] Read More

BOSTON, Massachusetts – October 24, 2025 – Today, S2N Health announced the launch of its first AI Agent for MedTech sales teams, marking a major milestone toward the company’s mission of transforming commercialization with data-enabled, AI-powered solutions that vastly improve […] Read More

At The MedTech Conference 2025, S2N Health CEO Amy Siegel moderated a dynamic discussion on how smart reimbursement planning drives commercial success, valuation, and ultimately, exit opportunities. The session, “Maximizing Value through Smart Reimbursement Strategies,” brought together voices from across […] Read More

As healthcare consolidation accelerates and purchasing power shifts to the system level, National Accounts leaders have become a linchpin in driving MedTech growth. To succeed, companies need to pair data-driven, systemwide selling strategies with C-suite engagement, evolving beyond purely product-focused […] Read More

BOSTON, Massachusetts, August 11, 2025 – Today, S2N Health, Inc. announced that Philadelphia-based Rittenhouse Ventures has completed an investment in S2N Health, joining current investors Excelerate Health Ventures, Boston Millennia Partners and Robin Hood Ventures in fueling the company’s rapid […] Read More

Drew Logan, VP of Sales & Marketing at Medtronic Endoscopy sits down with Amy Siegel, Co-Founder & CEO of S2N Health for a conversation about how AI is helping MedTech sales teams cut through data overload, delivering digestible insights that […] Read More

Today’s MedTech commercial teams don’t suffer from a lack of data—they’re often overwhelmed by it. From procedure volumes and referral patterns to sales history and market trends, the challenge isn’t finding data—it’s knowing how to use it. Without a focused […] Read More

CHALLENGE An enterprise medical device company and current RepSignal® user partnered with S2N Health to address a decline in orders for one of its GI diagnostic products, driven in part by suspected overstock at key accounts. While the product has […] Read More

In this episode of Tech Talks with Holly Scott, S2N Health CEO Amy Siegel shares the origin story of S2N Health and how her diverse background led to building a mission-driven company helping MedTech teams navigate the complex path to commercialization […] Read More

MedTech commercial teams are under relentless pressure to drive growth on shrinking resources. With 25–40% of company spend already going to sales and marketing, the only way to win is by using data to zero in on the highest-potential opportunities—and […] Read More

“I want to use AI, but my data is a mess and I’m not sure where to start.” If you lead a commercial team in MedTech, this statement might hit close to home. Whether in conversations with industry leaders, at […] Read More

Salesforce Issued Press Release SAN FRANCISCO, May 8, 2025 – Salesforce (NYSE: CRM), the #1 AI CRM, today announced a network of certified life sciences partners to accelerate customer migration to Life Sciences Cloud, its HIPAA-ready, pre-validated, GxP-compliant platform. Now, […] Read More

With over 25 years of experience across clinical, consulting, and strategic roles, I’ve seen the healthcare data landscape from every angle—provider, supplier, and strategist. One constant theme has emerged: there’s no shortage of data—but insight is another story. Across the […] Read More

S2N Health, a leader in AI-powered commercial intelligence solutions for MedTech companies, is proud to announce the appointment of Amy Brouhle, RN, BSN, MBA, MHA as Vice President of Strategic Business Development. This expansion of the senior leadership team will […] Read More

Disconnected Marketing and Sales approaches prevent many medtech companies from effectively driving customer engagement and revenue growth. Drawing on our experience with over 100 medtech companies, S2N Health has developed RepSignal—an AI-powered customer intelligence platform that bridges this critical gap. […] Read More

S2N Health’s analysis of CMS Open Payments data shows a notable concentration of vascular medtech companies engaging with a small group of key opinion leaders (KOLs). This highlights the need to diversify and expand the pool of clinical leaders contributing […] Read More

BOSTON, Massachusetts, October 29, 2024—Today, S2N Health and Healthcare Inroads (“HCIR”) announced their collaboration on supporting MedTech innovators and investors with an extended range of advisory services and market intelligence to maximize the impact for patients, providers, and companies. HCIR’s team brings […] Read More

Strategic pricing is critical for the success of a product. Price drives market adoption and long-term value capture. Getting pricing strategies right requires a deep understanding of how different market segments perceive the value of a product and how much […] Read More

We look forward to connecting with leading medtech innovators at this world-class event. This year, Amy Siegel, CEO & Co-Founder of S2N Health, will be moderating an all-star panel about today’s challenges in funding medtech innovations and actionable strategies to […] Read More

Director of Commercial Operations at Delphinus Medical Technologies, Mark Edwards reflects on the rapid market adoption of their novel breast imaging technology, which revolutionizes cancer screening in dense breast tissue and improves patient outcomes. The video below provides the highlights […] Read More

We are honored to welcome David Pierce, former EVP & President of Boston Scientific MedSurg, to the S2N Health Advisory Board. As a senior executive across BSC divisions and board member of multiple medtech companies, David brings invaluable expertise to […] Read More

Quality data is critical for strategic decision-making, yet many companies cannot effectively make use of the information they possess. Business analytics, market trends, competitive intelligence, sales activity and product information scattered across different software platforms and departments hinder effective coordination […] Read More

Healthcare data alone is not enough to give medtech innovators the edge they need. Historical procedure volumes or claims data don’t automatically highlight the most valuable opportunities. These data points also don’t directly reveal customer pain points or help with […] Read More

AI algorithms are more effective than human analysis when it comes to processing vast amounts of data. They can readily uncover patterns and provide prescriptive recommendations. Deploying AI can help medtech companies gain deeper insights into their customers, identify new […] Read More

Data and artificial intelligence are critical for today’s medtech companies to gain a competitive edge. For organizations utilizing Salesforce as their CRM, integrated data feeds and AI tools can unlock new levels of efficiency, insights, and growth. Actionable insights are […] Read More

BOSTON, Massachusetts, May 23, 2024 – Today, S2N Health, Inc. announced it successfully secured seed funding to fuel the growth of the company’s RepSignalTM medtech customer intelligence SaaS platform, and to develop a robust roadmap of AI-powered solutions for accelerating […] Read More

Over the last few decades, endovascular devices for stroke intervention and imaging technologies have become increasingly effective, allowing physicians to successfully treat a broader range of patients experiencing a stroke event. Neurovascular Device FDA 510(k) Clearances Technological advancements present a […] Read More

Meet us  at this premier event to find out how data combined with expert-curated, AI-powered analytics help innovators go to market with confidence. Let us show you how actionable insights guide commercial strategies every step of the way. Enhance pipeline […] Read More

S2N Health is excited to sponsor MEDTECH IMPACT Symposium & Gala on March 28 in Boston. This premier medtech event focuses on how data and AI can advance medical technology and personalize medicine. S2N Health accelerates this impact with AI-powered […] Read More

Dave Roberts, former SVP & President US at Medtronic is a revered industry leader whose career spanned major evolutions of how medical technologies are sold. Watch two short 3-minute extracts or the entire conversation with Amy Siegel and listen to […] Read More

CHALLENGE A leading medical technology company sought to enter the U.S. market for their home care solutions. Recognizing the strategic importance of home care, they planned to leverage a series of mergers and acquisitions (M&A) to rapidly build a comprehensive […] Read More

Top-performing medtech enterprises excel at innovation and product development (I&PD), maximize efficiencies, capitalize on their investments, expand their market presence, and deliver value to customers at an accelerated pace. What lies at the center of their success? [pullQuote quote=”Leading medtech […] Read More

Accurate site-level insights are critical. The success of new, tailored strategies hinges on understanding procedure volumes and types, ownership structures, and affiliations of ASCs. 20% are estimated to be either hospital-owned or affiliated, a factor that significantly influences the buying […] Read More

In recent discussions with industry innovators, investors, and solution providers, we provocatively imagined a future without traditional sales reps, and a shift towards alternative approaches to device sales. We’ve uncovered several key take-aways: Sales reps are integral but face evolving […] Read More

To understand the current challenges Medtech teams face and what enables them to succeed, we conducted 20 in-depth interviews with organizations ranging from emerging innovators to large enterprises. Surprisingly, the most common challenge mentioned across the board was not lead […] Read More

CHALLENGE A leading global medical company with novel patient monitoring technology faced a shifting market. Surgical procedures in key clinical areas including orthopedics, gastrointestinal, vascular, general surgery, and gynecology are increasingly migrating from traditional hospitals to Ambulatory Surgery Centers (ASCs). […] Read More